Ganetespib

N/A

Report date: 2026/03/30 20:02:02
NME

Base Information

Drug NameGanetespib
Drug Alias Name加特司匹ganetespibumganetespibADX-1612STA-9090 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsUveal melanomaOral Squamous Cell CarcinomaGastroesophageal Junction Neoplasms +[38] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBosnia and Herzegovina +[25] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMadrigal Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversitaire Ziekenhuizen Leuven
Inactive CompaniesDana-Farber Cancer InstituteGeorgetown UniversityCardiff University +[10] 
Active IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms
Inactive IndicationsUveal melanomaOral Squamous Cell CarcinomaGastroesophageal Junction Neoplasms +[35] 

Other Information

ATC CodeN/A
Related LinksKEGG